Questioning Diagnostic Value of Serum Matrix Metalloproteinase 7 for Biliary Atresia

Yang, 2018, Diagnostic accuracy of serum matrix metalloproteinase-7 for biliary atresia, Hepatology, 68, 2069, 10.1002/hep.30234 Shneider, 2016, Total serum bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia, J Pediatr, 170, 211, 10.1016/j.jpeds.2015.11.058 Mack, 2015, What causes biliary atresia? Unique aspects of the neonatal immune system provide clues to disease pathogenesis, Cellular and molecular gastroenterology and hepatology, 1, 267, 10.1016/j.jcmgh.2015.04.001 Jimenez-Rivera, 2013, International incidence and outcomes of biliary atresia, J Pediatr Gastroenterol Nutr, 56, 344, 10.1097/MPG.0b013e318282a913 Schreiber, 2020, Newborn screening for biliary atresia, JAMA, 323, 1137, 10.1001/jama.2020.2727 Brahee, 2022, Neonatal diagnosis of biliary atresia: a practical review and update, Pediatr Radiol, 52, 685, 10.1007/s00247-021-05148-y Thomas, 2018, MMP7 — a diagnostic biomarker for biliary atresia, Nat Rev Gastroenterol Hepatol, 15, 68, 10.1038/nrgastro.2017.175 Jiang, 2019, Serum MMP-7 in the diagnosis of biliary atresia, Pediatrics, 144, 10.1542/peds.2019-0902 Wong, 2019, What happens after Kasai for biliary atresia? A European multicenter survey, Eur J Pediatr Surg, 29, 1, 10.1055/s-0038-1668146 Rafeey, 2016, Diagnostic value of anti-smooth muscle antibodies and liver enzymes in differentiation of extrahepatic biliary atresia and idiopathic neonatal hepatitis, Afr J Paediatr Surg: AJPS (Asian J Plant Sci), 13, 63, 10.4103/0189-6725.182558 Tyraskis, 2016, Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy, Pediatr Surg Int, 32, 193, 10.1007/s00383-015-3836-3 Wang, 2018, Early differential diagnosis methods of biliary atresia: a meta-analysis, Pediatr Surg Int, 34, 363, 10.1007/s00383-018-4229-1 Dehghani, 2006, Comparison of different diagnostic methods in infants with cholestasis, World J Gastroenterol, 12, 5893, 10.3748/wjg.v12.i36.5893 He, 2021, Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis, Sci Rep, 11 Nomden, 2020, Current concepts of biliary atresia and matrix metalloproteinase-7: a review of literature, Front Med, 7, 10.3389/fmed.2020.617261 Kerola, 2016, Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia, J Pathol Clin Res, 2, 187, 10.1002/cjp2.50 Lam, 2020, Serum matrix metalloproteinase 7 is a diagnostic biomarker of biliary injury and fibrosis in pediatric autoimmune liver disease, Hepatology communications, 4, 1680, 10.1002/hep4.1589 Chen, 2016, Value of gamma-glutamyl transpeptidase for diagnosis of biliary atresia by correlation with age, J Pediatr Gastroenterol Nutr, 63, 10.1097/MPG.0000000000001168 Lertudomphonwanit, 2017, Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia, Sci Transl Med, 9, 10.1126/scitranslmed.aan8462 Wu, 2019, Quantification of serum matrix metallopeptide 7 levels may assist in the diagnosis and predict the outcome for patients with biliary atresia, J Pediatr, 208, 30, 10.1016/j.jpeds.2018.12.006 Rohani, 2022, Serum matrix metalloproteinase-7 levels in infants with cholestasis and biliary atresia, BMC Pediatr, 22, 351, 10.1186/s12887-022-03409-9